Stock market week-in-review for 5 large GI companies — Sept. 5-8

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Sept. 5 to Sept. 8, 2017.

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $226.78 on Sept. 5
Peaked: $234.59 on Sept. 8
Closed: $233.61 on Sept. 8
Percent change between Sept. 5 to Sept. 8: 3.01 percent

2. Exact Sciences Corp.

Opened: $41.61 on Sept. 5
Peaked: $43.27 on Sept. 7
Closed: $42.42 on Sept. 8
Percent change between Sept. 5 to Sept. 8: 1.92 percent

3. Johnson & Johnson

Opened: $130.34 on Sept. 5
Peaked: $132.49 on Sept. 7
Closed: $131.06 on Sept. 8
Percent change between Sept. 5 to Sept. 8: 0.55 percent

4. Synergy Pharmaceuticals

Opened: $3.01 on Sept. 5
Peaked: $3.11 on Sept. 5
Closed: $2.79 on Sept. 8
Percent change between Sept. 5 to Sept. 8: -7.3 percent

5. Valeant Pharmaceuticals

Opened: $13.32 on Sept. 5
Peaked: $13.56 on Sept. 8
Closed: $13.62 on Sept. 8
Percent change between Sept. 5 to Sept. 8: 2.25 percent

More articles on gastroenterology:
CapsoVision launches CapsoCloud to make CapsoCam data extraction easier — 3 key notes
GI leader to know: Dr. Marla Dubinsky of Mount Sinai Hospital
FDA grants Innovate Biopharma's ulcerative colitis drug orphan designation — 3 insights

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months